Mechanisms of the intestinal and urinary microbiome in kidney stone disease

Kidney stone disease affects similar to 10% of the global population and the incidence continues to rise owing to the associated global increase in the incidence of medical conditions associated with kidney stone disease including, for example, those comprising the metabolic syndrome. Considering that the intestinal microbiome has a substantial influence on host metabolism, that evidence has suggested that the intestinal microbiome might have a role in maintaining oxalate homeostasis and kidney stone disease is unsurprising. In addition, the discovery that urine is not sterile but, like other sites of the human body, harbours commensal bacterial species that collectively form a urinary microbiome, is an additional factor that might influence the induction of crystal formation and stone growth directly in the kidney. Collectively, the microbiomes of the host could influence kidney stone disease at multiple levels, including intestinal oxalate absorption and direct crystal formation in the kidneys.

Automated summary

Kidney stone disease affects around 10% of the global population and its incidence is increasing due to the rise in medical conditions associated with the disease. The intestinal microbiome and the presence of commensal bacterial species in urine could influence the development of kidney stone disease.